Summary of Study ST001215
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000811. The data can be accessed directly via it's Project DOI: 10.21228/M8VD62 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST001215 |
Study Title | Effect of Mirabegron Treatment on serum lipidome |
Study Summary | Determine the lipidome changes in the serum of human subjects treated with a single dosage (200mg) of the beta-3 adrenoceptor agonist Mirabegron. |
Institute | Joslin Diabetes Center |
Last Name | Leiria |
First Name | Luiz |
Address | One Joslin Place, 02215, Boston, MA-USA |
luiz.leiria@joslin.harvard.edu | |
Phone | 617-309-1967 |
Submit Date | 2016-10-23 |
Raw Data Available | Yes |
Raw Data File Type(s) | wiff |
Analysis Type Detail | LC-MS |
Release Date | 2019-09-23 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Treatment:
Treatment ID: | TR001297 |
Treatment Summary: | Healthy volunteers were recruited through electronic advertisements and provided written informed consent. The subjects were given a single oral dose of mirabegron, 200 mg. |